Revenue Components (Tables)

9 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table provides information about the Company’s revenues for the three and nine months ended December 31, 2021 and 2020 (in thousands):

	Three Months Ended December 31,				Nine Months Ended December 31,
	2021		2020		2021		2020
Revenues:
Product revenue, net:
ORGOVYX	$	24,393	$	—	$	53,535	$	—
MYFEMBREE	2,429		—		4,133		—
Richter product supply and royalties	2,446		—		4,217		—
Total product revenue, net	29,268		—		61,885		—
Pfizer collaboration revenue:
Amortization of upfront payment	20,974		1,379		62,922		1,379
Amortization of regulatory milestone	4,198		—		16,931		—
Total Pfizer collaboration revenue	25,172		1,379		79,853		1,379
Richter license and milestone revenue	—		—		31,667		33,333
Total revenues	$	54,440	$	1,379	$	173,405	$	34,712